
|Articles|November 26, 2012
Ranbaxy recalls atorvastatin calcium tablets in 10-, 20-, 40-mg dosages
More than 40 lots of atorvastatin calcium tablets, the generic version of Pfizer?s Lipitor, are being recalled by Ranbaxy Pharmaceuticals Inc. (RPI) because they may contain glass particles that are estimated to be less than 1 mm in size, according to Ranbaxy's website.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
Study Identifies Patients at Risk for Severe COVID-19 Post-Vaccination
2
Zepbound Lowers Health Care Costs in Older Adults With Obesity
3
Ixekizumab, Tirzepatide Maintains Efficacy in Psoriatic Disease
4
Measles Resurgence Exposes US Vaccine Policy Risks, Experts Warn
5






































